Europa Biosite has announced the acquisition of AMSBIO, a supplier of life science products and services, with expertise in the areas of biospecimens, stem cell research, 3D cell culture, glycobiology, and molecular biology.
After hearing the news of Cytiva and Syvento Bitotech's new facility, European Pharmaceutical Manufacturer followed up with Ludovic Brellier, president of Hardware Solutions at Cytiva, for more information.
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy.
SyVento Biotech has opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7 000 m2, including lab and production areas, offices, and shared spaces.
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
FUJIFILM Diosynth Biotechnologies has announced that the first phase of its expansion at the Hillerød site is ready to bring the new production capacity into operation.
Lonza announced the completion of the first GMP product batch supported from the recently completed next-generation mammalian manufacturing facility in Portsmouth (US).
Cytomos has raised £5 million to scale up production of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt.
